Close Menu

NEW YORK (360Dx) – Lucence Diagnostics said today that it is teaming with Stanford University School of Medicine to develop artificial intelligence algorithms for improving diagnosis and treatment of liver cancer by analyzing both imaging and molecular data.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.